These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 73664)
1. Bioavailability after intramuscular injection. Jonkman JH; van Bork LE; de Zeeuw RA; Orie NG Lancet; 1976 Mar; 1(7961):693. PubMed ID: 73664 [No Abstract] [Full Text] [Related]
2. Variations in the bioavailability of thiazinamium methylsulfate. Jonkman JH; Van Bork LE; Wijsbeek J; De Zeeuw RK; Orie NG Clin Pharmacol Ther; 1977 Apr; 21(4):457-63. PubMed ID: 849677 [TBL] [Abstract][Full Text] [Related]
3. First-pass effect after rectal administration of thiazinamium methylsulfate. Jonkman JH; van Bork LE; Wijsbeek J; Bolhuis-de Vries AS; de Zeeuw RA; Orie NG; Cox HL J Pharm Sci; 1979 Jan; 68(1):69-72. PubMed ID: 758468 [TBL] [Abstract][Full Text] [Related]
4. Proceedings: Bioavailability of the quaternary ammonium compound thiazinamium methylsulphate (Multergan) after oral and intramuscular administration. Jonkman JH; Wijsbeek U; Brouwer SH; De Zeeuw RA J Pharm Pharmacol; 1974 Dec; 26 Suppl():63P. PubMed ID: 4156742 [No Abstract] [Full Text] [Related]
5. High-pressure liquid chromatographic determination of promethazine plasma levels in the dog after oral, intramuscular, and intravenous dosage. Patel RB; Welling PG J Pharm Sci; 1982 May; 71(5):529-32. PubMed ID: 7097498 [TBL] [Abstract][Full Text] [Related]
6. Human whole blood and parotid saliva concentrations of oral and intramuscular promethazine. DiGregorio GJ; Ruch E J Pharm Sci; 1980 Dec; 69(12):1457-9. PubMed ID: 7463341 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the bioavailability of oral, rectal and intramuscular promethazine. Schwinghammer TL; Juhl RP; Dittert LW; Melethil SK; Kroboth FJ; Chung VS Biopharm Drug Dispos; 1984; 5(2):185-94. PubMed ID: 6743785 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of promethazine and its sulphoxide metabolite after intravenous and oral administration to man. Taylor G; Houston JB; Shaffer J; Mawer G Br J Clin Pharmacol; 1983 Mar; 15(3):287-93. PubMed ID: 6849764 [TBL] [Abstract][Full Text] [Related]
9. Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate (Multergan) in man. I. Parenteral administration. Jonkman JH; Wijsbeek J; De Zeeuw RA; Van Bork LE; Orie NG; Soeterboek AM; Bender J Pharm Weekbl Sci; 1982 Oct; 4(5):122-8. PubMed ID: 6128713 [TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of intramuscular thiazinamium methyl sulfate. Jonkman JH; Van Bork LE; Calvert B; Greving JE; Wijsbeek J; De Zeeuw RA; Orie NG Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):454-9. PubMed ID: 6138313 [TBL] [Abstract][Full Text] [Related]
11. "First pass effect" after rectal administration of thiazinamium methylsulphate [proceedings]. Jonkman JH; van Bork LE; Wijsbeek J; de Zeeuw RA; Orie NG; Cox HL J Pharm Pharmacol; 1976 Dec; 28 Suppl():56P. PubMed ID: 12333 [No Abstract] [Full Text] [Related]
12. Changes in the disposition of promethazine during multiple dosing in the rabbit. Taylor G; Houston JB J Pharm Pharmacol; 1985 Apr; 37(4):243-7. PubMed ID: 2860221 [TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics of promethazine after intravenous administration in camels. Wasfi IA; Barezaiq IM; Alkatheeri N; Hadi AA; Boni NS; Almuhrami AM; Elghazali M Res Vet Sci; 1999 Apr; 66(2):159-60. PubMed ID: 10208894 [TBL] [Abstract][Full Text] [Related]
14. Influence of simulated weightlessness on the intramuscular and oral pharmacokinetics of promethazine in 12 human volunteers. Gandia P; Saivin S; Le-Traon AP; Guell A; Houin G J Clin Pharmacol; 2006 Sep; 46(9):1008-16. PubMed ID: 16920895 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic profile of cefotaxime in goats. Atef M; Ramadan A; Afifi NA; Youssef SA Res Vet Sci; 1990 Jul; 49(1):34-8. PubMed ID: 2382053 [TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of cefodizime following intravenous and intramuscular administration of a single dose of 1.0 g. Bryskier A; Procyk T; Tremblay D; Lenfant B; Fourtillan JB J Antimicrob Chemother; 1990 Nov; 26 Suppl C():59-63. PubMed ID: 2074252 [TBL] [Abstract][Full Text] [Related]
17. [Absolute bioavailability of chlorpromazine, promazine and promethazine]. Koytchev R; Alken RG; Kirkov V; Neshev G; Vagaday M; Kunter U Arzneimittelforschung; 1994 Feb; 44(2):121-5. PubMed ID: 8147942 [TBL] [Abstract][Full Text] [Related]
18. [Diagnostic and therapeutic use of thiazinamium (Multergan)]. van Bork LE; Jonkman JH; de Zeeuw RA; Orie NG; Peset R; de Vries K Ned Tijdschr Geneeskd; 1977 Jul; 121(30):1196-202. PubMed ID: 887179 [No Abstract] [Full Text] [Related]
19. Hepatic first-pass effect of thiazinamium methylsulfate (N-methylpromethazine methylsulfate) in dogs. Jonkman JH; Westenberg HG; Van Der Kleyn E J Pharm Sci; 1981 Aug; 70(8):947-9. PubMed ID: 6118426 [TBL] [Abstract][Full Text] [Related]
20. Determinants of systemic availability of promethazine in rabbits. Taylor G; Houston JB J Pharm Pharmacol; 1983 May; 35(5):284-8. PubMed ID: 6134795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]